- Report
- April 2024
- 30 Pages
Global
From €3139EUR$3,250USD£2,684GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- February 2024
- 90 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 150 Pages
Global
From €4588EUR$4,750USD£3,923GBP
From €6279EUR$6,500USD£5,369GBP
- Report
- February 2024
- 150 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- January 2024
- 189 Pages
Global
From €7245EUR$7,500USD£6,195GBP
- Report
- January 2024
- 200 Pages
Global
From €4009EUR$4,150USD£3,428GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 80 Pages
Europe
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 90 Pages
Middle East, Africa
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 70 Pages
North America
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 70 Pages
Europe
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4588EUR$4,750USD£3,923GBP
- Report
- February 2024
- 70 Pages
United States
From €4588EUR$4,750USD£3,923GBP
- Report
- August 2023
- 70 Pages
Middle East, Africa
From €4588EUR$4,750USD£3,923GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4588EUR$4,750USD£3,923GBP
- Report
- August 2023
- 150 Pages
North America
From €4588EUR$4,750USD£3,923GBP
Jardiance is a medication used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by blocking the reabsorption of glucose in the kidneys, allowing it to be excreted in the urine. This helps to lower blood sugar levels. Jardiance is typically used in combination with other diabetes medications, such as metformin, to help control blood sugar levels.
Jardiance is part of a larger market of endocrine and metabolic disorder drugs, which includes medications used to treat conditions such as obesity, thyroid disorders, and polycystic ovary syndrome. These drugs are used to help regulate hormones and metabolism, and can help to improve overall health and quality of life.
Companies in the Jardiance market include Boehringer Ingelheim, Merck, and Eli Lilly. Show Less Read more